Five things to know:
1. Victor Law, president of the Board of Pharmacy for the Department of Consumer Affairs, signed an order forcing Newhall Pharmacy to surrender its license.
2. Under the order, the pharmacy is unable to apply for a new license for three years.
3. Newhall Pharmacy first came under scrutiny in April 2015, when the board received an anonymous tip that the pharmacy was selling oxycodone and codeine-based cough syrup to people who didn’t have prescriptions. An inspector visited the pharmacy after the tip and found nine violations.
4. The investigation found that there were “multiple discrepancies” between the quantities of oxycodone dispensed and prescription and drug-dispensing records.
5. All together, the inspection found there was an inventory shortage of 2,748 pills of oxycodone, 400 pills of oxycodone/APAP and 322 missing bottles of codeine-based cough syrup, according to the report.
Read the full report here.
More articles on pharmacy:
CMS targets spread pricing in new guidance
The Met turns down gifts from Purdue Pharma’s Sackler family
CVS to test all vitamins, supplements
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.